vcvibes

Excelerate Health Ventures LLCFirm match from fund name (lower confidence)

Excelerate Health Ventures III LP

RaisingEmerging manager

Raising: Form D filed Apr 2026 reports an open-ended (indefinite) offering

Vintage
2026
Fund size
$21.85M (Form D)
Stages
Seed, Series A
Sectors
Healthtech, Enterprise SaaS
Regions
US

01 · Thesis

Invests in Pharma Tech, B2B SaaS and tech-enabled pharma services, with a focus on AI-powered pharma technology. Backs capital-efficient models built to scale, typically at seed and Series A stages, often leading or co-leading rounds.Inferred from the firm's website

02 · Initial check

$500K to $2M (stated by the firm)

Stated by the firm (firm-level)

03 · Who to approach

Named on this fund's Form D

  • Andrew Schwab, Managing Partner of the Manager of the General Partner of the Issuer
  • Maulik Mehta, Manager of the Manager of the General Partner of the Issuer
  • B. Bahram, Managing Partner of the Manager of the General Partner of the Issuer

04 · Deals

No deals attributed to this fund yet.

05 · Evidence

  • Firm-wideA fund focused on AI-powered Pharma Tech and tech-enabled pharma services for early-stage companies. Its initial closing was announced in April 2026.

    We have created a premier AI-Powered Pharma Tech and Services fund for early-stage companies.
    https://exceleratehealth.com/approach/
  • Firm-wideChecks of $500000 to $2000000

    initial checks of $500K–$2M
    https://exceleratehealth.com/approach/
  • Firm-wideAn earlier healthcare fund that backed capital-efficient healthcare software companies across provider, payer, and pharma markets.

    Our earlier funds backed capital-efficient healthcare software companies across provider, payer, and pharma markets.
    https://exceleratehealth.com/portfolio/
  • Firm-wideInvests exclusively in Pharma Tech, B2B SaaS and tech-enabled services with capital-efficient models built to scale.

    We invest exclusively in Pharma Tech, B2B SaaS and tech-enabled services with capital-efficient models built to scale.
    https://exceleratehealth.com/approach/
  • Firm-wideChecks of $500000 to $2000000

    initial checks of $500K–$2M
    https://exceleratehealth.com/approach/

06 · Sources

  1. https://exceleratehealth.com/approach/
  2. https://exceleratehealth.com/portfolio/
  3. https://www.sec.gov/Archives/edgar/data/2095764/000209576426000001/

Last verified: Oct 28, 2026